-
ICD-10-CM Codes
›
-
D50-D89
›
-
D65-D69
›
-
D69-
›
-
2023 ICD-10-CM Diagnosis Code D69.1
2023 ICD-10-CM Diagnosis Code D69.1
Qualitative platelet defects
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- D69.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM D69.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D69.1 - other international versions of ICD-10 D69.1 may differ.
Applicable To- Bernard-Soulier [giant platelet] syndrome
- Glanzmann's disease
- Grey platelet syndrome
- Thromboasthenia (hemorrhagic) (hereditary)
- Thrombocytopathy
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D69.1. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Type 2 ExcludesType 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (D69.1) and the excluded code together.
The following code(s) above
D69.1 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D69.1:
- Platelet disorder
- Platelet disorder, qualitative
- Platelet dysfunction due to drugs
- Platelet dysfunction, drug induced
- Qualitative platelet disorder
Clinical Information
- A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, especially adp, and impaired or absent clot retraction. Platelet membranes are deficient in or have a defect in the glycoprotein iib-iiia complex (platelet glycoprotein gpiib-iiia complex).
- A rare inherited bleeding disorder characterized by the decrease or absence of the platelet alpha-granules and their proteins in the peripheral blood platelets.
- A rare, autosomal recessive inherited and less frequently acquired platelet disorder. It is characterized by deficient or dysfunctional glycoprotein iib/iiia complex. It leads to defective platelet aggregation, resulting in bleeding.
- A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with thrombocytopenia, enlarged platelets, and prolonged bleeding time.
- Platelet abnormality characterized by defective clot formation, impaired aggregation, and prolonged bleeding time; other manifestations include nosebleeds, inappropriate bruising, and excessive bleeding.
ICD-10-CM D69.1 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 813 Coagulation disorders
Convert D69.1 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to D69.1:
- Bernard-Soulier disease or thrombopathia D69.1
- Defect, defective Q89.9
ICD-10-CM Diagnosis Code Q89.9
Congenital malformation, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Congenital anomaly NOS
- Congenital deformity NOS
- Deficiency, deficient
- Diacyclothrombopathia D69.1
- Disease, diseased - see also Syndrome
- Bernard-Soulier D69.1 (thrombopathy)
- Glanzmann's D69.1 (hereditary hemorrhagic thrombasthenia)
- Naegeli's D69.1
- Disorder (of) - see also Disease
- Dysfunction
- Glanzmann D69.1 (-Naegeli)
- Syndrome - see also Disease
- gray or grey (newborn) P93.0
ICD-10-CM Diagnosis Code P93.0
Grey baby syndrome
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Code on Newborn Record
Applicable To- Grey syndrome from chloramphenicol administration in newborn
- giant platelet D69.1 (Bernard-Soulier)
- Thrombasthenia D69.1 (Glanzmann) (hemorrhagic) (hereditary)
- Thromboasthenia D69.1 (Glanzmann) (hemorrhagic) (hereditary)
- Thrombocytasthenia D69.1 (Glanzmann)
- Thrombocytopathy D69.1 (dystrophic) (granulopenic)
- Thrombopathy (Bernard-Soulier) D69.1
ICD-10-CM Codes Adjacent To D69.1
D68.52 Prothrombin gene mutation
D68.59 Other primary thrombophilia
D68.6 Other thrombophilia
D68.61 Antiphospholipid syndrome
D68.62 Lupus anticoagulant syndrome
D68.8 Other specified coagulation defects
D68.9 Coagulation defect, unspecified
D69 Purpura and other hemorrhagic conditions
D69.1
Qualitative platelet defects
D69.2 Other nonthrombocytopenic purpura
D69.3 Immune thrombocytopenic purpura
D69.4 Other primary thrombocytopenia
D69.42 Congenital and hereditary thrombocytopenia purpura
D69.49 Other primary thrombocytopenia
D69.5 Secondary thrombocytopenia
D69.51 Posttransfusion purpura
D69.59 Other secondary thrombocytopenia
D69.6 Thrombocytopenia, unspecified
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
